Auraptene
CAS: 495-02-3
Rif. TM-T4115
5mg | 35,00 € | ||
10mg | 46,00 € | ||
25mg | 64,00 € | ||
50mg | 82,00 € | ||
100mg | 134,00 € | ||
500mg | 315,00 € | ||
1ml*10 (DMSO) | 54,00 € |
Informazioni sul prodotto
- 7-geranyloxycoumarin
- (E)-7-Geranoxycoumarin
- 2H-1-Benzopyran-2-one, 7-((3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-
- 2H-1-Benzopyran-2-one, 7-[[(2E)-3,7-dimethyl-2,6-octadienyl]oxy]-
- 2H-1-benzopyran-2-one, 7-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]-
- 7-Geranyloxycoumarin
- 7-[[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy]-2H-1-benzopyran-2-one
- 7-{[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy}-2H-chromen-2-on
- 7-{[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy}-2H-chromen-2-one
- Aurapten
- Vedi altri sinonimi
- Aurapten (C<sub>19</sub>H<sub>22</sub>O<sub>3</sub>)
- Coumarin, 7-(geranyloxy)-
- Coumarin, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-
- Rapten
Auraptene is a coumarin derived from citrus plants that bears a geranyloxyl moiety at its C-7. It has anti-inflammatory, anti-carcinogenic, anti-bacterial, neuroprotective, and hepatoprotective activities. It inhibits leukocyte activation and induces phase II enzymes during the initiation phase of carcinogenesis.1 When examined for its potential use in Alzheimer's disease treatment, auraptene was shown to inhibit β-secretase (BACE1) activity with an IC50 value of 345.1 μM.
Proprietà chimiche
Richiesta tecnica su: TM-T4115 Auraptene
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.